(Date:12/1/2008)... Americans United for Life (AUL) today announces t... opposing the federal "Freedom of Choice Act" (FOC...olution immediately when they convene their 2009 s...dent & CEO said, "The so-called ,Freedom of Ch...nd promotes the abortion industry, sacrifices the ...
(Date:12/1/2008)...Senetek PLC,(OTC Bulletin Board: SNKTY), a life s...hnologies that target the science of healthy aging...ists in the fields of strategic,development, comm...Zurich,Bern and Geneva has published a Research ...t, available in the "Investors" section of the Com...
(Date:12/1/2008)...in some, study says , , MONDAY, Dec. 1 (...larly have increased blood flow and more small blo...he University of North Carolina (UNC) study, expec...iety of North America (RSNA) annual meeting, in Ch...e prevents cognitive decline in the elderly. , ...
(Date:12/1/2008)...r relief campaign , , WASHINGTON, Dec. 1 /P... asking people across the nation to help disaster ...liday season push will put the final touch on the ...isaster Relief. Already, the campaign has raised n...nd the Red Cross hopes to meet its target before t...
Breaking Medicine News(10 mins):Health News:Americans United for Life Urges State Legislatures to Oppose Federal Power Grab: Provides Model Resolution Denouncing Freedom of Choice Act (FOCA) 2Health News:Red Cross Asks America to Help Raise $30 Million in 30 Days 2Health News:Red Cross Asks America to Help Raise $30 Million in 30 Days 3...ent more sudden deaths than defibrillators in home...rs according to US scientists.// Researchers at Re...reventive strategies by food supplementation and b...ulated community of 100,000 people that resembled ...
...people are hairier than others may have been disco...ecular mechanisms that determine which embryonic s...the body's hair pattern has been discovered by the...Manchester. This study on mice will be of use in ...
...the people in the US do not wash their hands prope...wly formed had conducted the survey of 8,000 peopl...ticipants had been chosen from around U.S., U.K., ... Emirates, India, Malaysia, and South Africa. Lys...
...d by the Australian government states that surgery...cost effective option to control// the growing epi...d that to have found the various programs based in...ed questions about the effectiveness of some. It i...
Other Medicine News:Health News:Health Experts In Australia Toy With The Idea Of Surgery for Controlling Obesity In Teenagers 2(Date:11/27/2008)...mphoblastic leukemia relapse cases arise from a ce..., MEMPHIS, Tenn., Nov. 27 /PRNewswire-USNewswir...ospital have identified distinctive genetic change...oblastic leukemia (ALL) that cause relapse. The fi... ALL relapse in children and, ultimately, in adult...
(Date:11/25/2008)...ewswire/ -- Kleinert Kutz and University of Louis... transplant on Messina, New York resident, Jan "Er... Care Center on Monday, November 24. The innovati...hortly after 9 p.m. in a record nine hours. , .../20081125/DC48555-a ) , (Photo: http://www.ne...
(Date:11/25/2008)...to Assess Survival of Patients Receiving Litx vers...atocellular Carcinoma , , BELLEVUE, Wash., ...nc. (LSO) today announced the completion of enroll...nfusion Therapy(TM) (Litx(TM)) as a treatment for ...known as hepatoma or primary liver cancer. , ,...
(Date:11/24/2008)...Month , , Oak Brook, Ill., Nov. 24 /PRNewsw...ointestinal Endoscopy (ASGE) and the Pancreatic Ca...o raise awareness about pancreatic cancer, educati...at are available for them. , , Pancreatic c... in the U.S. In 2008, an estimated 37,680 American...
Breaking Medicine Technology:St. Jude Identifies Genomic Causes of a Certain Type of Leukemia Relapse 2St. Jude Identifies Genomic Causes of a Certain Type of Leukemia Relapse 3Kleinert Kutz Hand Surgeons Perform Fifth U.S. Hand Transplant in Record Time at Jewish Hospital Hand Care Center 2Kleinert Kutz Hand Surgeons Perform Fifth U.S. Hand Transplant in Record Time at Jewish Hospital Hand Care Center 3Light Sciences Oncology Completes Patient Enrollment in Phase 3 Clinical Trial of Litx as a Treatment for Hepatocellular Carcinoma 2Light Sciences Oncology Completes Patient Enrollment in Phase 3 Clinical Trial of Litx as a Treatment for Hepatocellular Carcinoma 3Light Sciences Oncology Completes Patient Enrollment in Phase 3 Clinical Trial of Litx as a Treatment for Hepatocellular Carcinoma 4ASGE and The Pancreatic Cancer Action Network Partner to Raise Awareness About Pancreatic Cancer 2ASGE and The Pancreatic Cancer Action Network Partner to Raise Awareness About Pancreatic Cancer 3ASGE and The Pancreatic Cancer Action Network Partner to Raise Awareness About Pancreatic Cancer 4ASGE and The Pancreatic Cancer Action Network Partner to Raise Awareness About Pancreatic Cancer 5ASGE and The Pancreatic Cancer Action Network Partner to Raise Awareness About Pancreatic Cancer 6Health Care Leaders to Use New National Criteria for Patient Centered Medical Home 5724 1Health Care Leaders to Use New National Criteria for Patient Centered Medical Home 5724 2Health Care Leaders to Use New National Criteria for Patient Centered Medical Home 5724 3Health Care Leaders to Use New National Criteria for Patient Centered Medical Home 5724 4Linnartz New Head of Investor Relations of Gerresheimer 5722 1Unilabs Q1 2007 2008 Earnings Conference Call 5720 1Unilabs Q1 2007 2008 Earnings Conference Call 5720 2Vital Therapies Announces Presentation of ELAD 28R 29 Artificial Liver Data at American Association for the Study of Liver Diseases 2007 Annual Meetin 783 1Vital Therapies Announces Presentation of ELAD 28R 29 Artificial Liver Data at American Association for the Study of Liver Diseases 2007 Annual Meetin 783 2... LEXINGTON, Mass.--(BUSINESS WIRE)--Apr 18, 2007 -...ed today positive,cognitive function results from ...l of PRX-07034, the company,s,internally-discovere...ity, Alzheimer,s disease and cognitive impairment ...uble-blind, placebo-controlled Phase 1b,multiple ...
... - Results Reported at the American Association fo..., April 18, 2007 /PRNewswire/ - Viventia Biotech I...vancing a portfolio of,novel antibody products foc...o cytotoxicity and in vivo pharmacokinetic studies... its phase III,anti-cancer antibody therapeutic, P...
Other Medicine Technology:EPIX Pharmaceuticals Announces Statistically Significant Results in,Cognitive Function from Phase 1b Clinical Trial of Novel 5-HT6 Drug,Candidate 2EPIX Pharmaceuticals Announces Statistically Significant Results in,Cognitive Function from Phase 1b Clinical Trial of Novel 5-HT6 Drug,Candidate 3EPIX Pharmaceuticals Announces Statistically Significant Results in,Cognitive Function from Phase 1b Clinical Trial of Novel 5-HT6 Drug,Candidate 4Viventia biotech reports synergystic effect of its Proxinium,antibody in combinaton with chemotherapy and radiation 2Viventia biotech reports synergystic effect of its Proxinium,antibody in combinaton with chemotherapy and radiation 3...y Urea (Nitrogen) powder reagent once reconstitute...gle liquid stability to help maximize laboratory p...uick result turnaround time. The patented technolo...provides a long shelf life and stability once reco...
The Infinity Triglycerides single liquid stable reagent offers the laboratory all the convenience of single liquid stability to help maximize laboratory productivity, minimize operator error and prov
The Infinity Creatinine single liquid stable reagent offers the laboratory all the convenience of single liquid stability to help maximize laboratory productivity, minimize operator error and provide
The Infinity AST (GOT) powder reagent once reconstituted offers the laboratory all the convenience of single liquid stability to help maximize laboratory productivity, minimize operator error and pro
Medicine Products: